← Evidence map

ArticleBiomedicines2026

Network Pharmacology Identifies IKBKB as the Primary Target of Sinomenine in Osteoarthritis, with Accuracy Benchmarking and Orthogonal Validation.

Yifei Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Network Pharmacology Identifies IKBKB as the Primary Target of Sinomenine in Osteoarthritis, with Accuracy Benchmarking and Orthogonal Validation. | OpenQuestion